Use of D-Penicillamine in the Neonatal Hyperbilirubinemias by Lajos Lakatos in TBSND - Juniper Publishers
D-penicillamine (DPA) was first recognized as a potential benefit for neonatal hyperbilirubinemia (NHBI) caused by hemolytic diseases or immaturity of UDP-glucuronyltransferase enzyme. During this time there was a remarkedly low incidence of retinopathy of prematurity (ROP) in the infants treated with DPA. Later, our studies were replicated in other institutes in Hungary, Poland, U.S. A., India and Mexico. It is important to note that there was no intolerance or short- or long-term toxicity of the medication, in spite of the fact that in the newborn period DPA was used 10-20 times higher doses than those in adult.
I wasted a lot of money trying to find the right medication for my moms dementia all to no avail until Dr Erayo showed up and eradicated the stigma with the natural roots and herbs i ordered from him , my mom took it for 21days and she was cured from her dementia.
ReplyDeleteGod have use Dr Erayo herbal home to cure my mom, thank you so much Dr Erayo I am so happy. You can email Dr Erayo for help drerayoherbalhome@gmail.com
or whatsapp him on +2348151937428
website---- https://alternativeherbs.weebly.com
Youtube link---- https://www.youtube.com/channel/UCSp2m-_EHnCRQT4gYYTQWtg
FB page---- https://rb.gy/yuofn6